SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-025656
Filing Date
2019-05-01
Accepted
2019-05-01 06:02:42
Documents
70
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7386_110q.htm 10-Q 1288596
2 EX-31.1 a19-7386_1ex31d1.htm EX-31.1 12938
3 EX-31.2 a19-7386_1ex31d2.htm EX-31.2 12936
4 EX-32.1 a19-7386_1ex32d1.htm EX-32.1 7325
5 EX-32.2 a19-7386_1ex32d2.htm EX-32.2 7324
  Complete submission text file 0001104659-19-025656.txt   7560661

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT uthr-20190331.xml EX-101.INS 1994424
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20190331.xsd EX-101.SCH 54808
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20190331_cal.xml EX-101.CAL 57853
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20190331_def.xml EX-101.DEF 258894
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20190331_lab.xml EX-101.LAB 531456
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20190331_pre.xml EX-101.PRE 392387
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 19784614
SIC: 2834 Pharmaceutical Preparations